TG Therapeutics, Inc. (TGTX)
31.98
+1.38
(+4.51%)
USD |
NASDAQ |
Dec 11, 16:00
32.00
+0.02
(+0.06%)
After-Hours: 20:00
TG Therapeutics Free Cash Flow: -70.24M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Karyopharm Therapeutics, Inc. | -89.30M |
| Axsome Therapeutics, Inc. | -101.39M |
| Krystal Biotech, Inc. | 165.59M |
| Arcutis Biotherapeutics, Inc. | -48.24M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.15M |
| Cash from Investing (Quarterly) | 46.36M |
| Cash from Financing (Quarterly) | -78.24M |
| Free Cash Flow Per Share (Quarterly) | -0.1443 |
| Free Cash Flow to Equity (Quarterly) | -23.23M |
| Free Cash Flow to Firm (Quarterly) | 78.17M |
| Free Cash Flow Yield | -1.36% |